XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Adoption of ASC 842
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Adoption of ASC 842
Accumulated Other Comprehensive Loss
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021     1,611,392,000          
Beginning balance at Dec. 31, 2021 $ 1,567,379 $ 5,195 $ 161 $ 3,804,844 $ (2,297,925) $ 5,195 $ (1,715) $ 62,014
Issuance of common stock upon exercise or vesting of equity awards (in shares)     29,025,000          
Issuance of common stock upon exercise or vesting of equity awards 123   $ 3 120        
Tax withholdings related to net share settlement of equity awards (in shares)     (296,000)          
Tax withholdings related to net share settlement of equity awards (981)     (981)        
Settlement of contingent consideration [1] 0              
Issuance of common stock for asset acquisition (in shares)     8,142,000          
Issuance of common stock for asset acquisition 27,720   $ 1 27,719        
Stock-based compensation expense and other 1,839,316     1,837,089       2,227
Foreign currency translation adjustment (6,195) [2]           (6,195)  
Net loss (1,933,294) [2],[3]       (1,929,461)     (3,833)
Deconsolidation of subsidiaries (55,408)             (55,408)
Ending balance (in shares) at Sep. 30, 2022 [4]     1,648,263,000          
Ending balance at Sep. 30, 2022 [4] 1,443,855   $ 165 5,668,791 (4,222,191)   (7,910) 5,000
Beginning balance (in shares) at Jun. 30, 2022     1,635,634,000          
Beginning balance at Jun. 30, 2022 1,572,251   $ 164 5,098,018 (3,552,060)   (5,496) 31,625
Issuance of common stock upon exercise or vesting of equity awards (in shares)     10,041,000          
Issuance of common stock upon exercise or vesting of equity awards 45   $ 1 44        
Issuance of common stock for asset acquisition (in shares)     2,588,000          
Issuance of common stock for asset acquisition 7,592     7,592        
Stock-based compensation expense and other 563,137     563,137       0
Foreign currency translation adjustment (2,414) [2]           (2,414)  
Net loss (670,131) [2]       (670,131)      
Deconsolidation of subsidiaries (26,625)             (26,625)
Ending balance (in shares) at Sep. 30, 2022 [4]     1,648,263,000          
Ending balance at Sep. 30, 2022 [4] $ 1,443,855   $ 165 5,668,791 (4,222,191)   (7,910) $ 5,000
Beginning balance (in shares) at Dec. 31, 2022 1,891,976,000   1,891,976,000          
Beginning balance at Dec. 31, 2022 $ 1,736,277   $ 190 6,136,378 (4,397,659)   (2,632)  
Issuance of common stock upon exercise or vesting of equity awards (in shares)     75,480,000          
Issuance of common stock upon exercise or vesting of equity awards 539   $ 8 531        
Tax withholdings related to net share settlement of equity awards (in shares)     (14,000)          
Tax withholdings related to net share settlement of equity awards (23)     (23)        
Settlement of contingent consideration (in shares)     440,000          
Settlement of contingent consideration 3,222     3,222        
Issuance of common stock for asset acquisition (in shares)     2,820,000          
Issuance of common stock for asset acquisition 3,581     3,581        
Issuance of common stock in exchange for services (in shares)     2,023,000          
Issuance of common stock in exchange for services 2,500     2,500        
Stock-based compensation expense and other 188,029     188,029        
Foreign currency translation adjustment (267)           (267)  
Net loss $ (681,175)       (681,175)      
Ending balance (in shares) at Sep. 30, 2023 1,972,725,000   1,972,725,000          
Ending balance at Sep. 30, 2023 $ 1,252,683   $ 198 6,334,218 (5,078,834)   (2,899)  
Beginning balance (in shares) at Jun. 30, 2023     1,954,704,000          
Beginning balance at Jun. 30, 2023 1,503,585   $ 196 6,280,632 (4,775,943)   (1,300)  
Issuance of common stock upon exercise or vesting of equity awards (in shares)     17,581,000          
Issuance of common stock upon exercise or vesting of equity awards 55   $ 2 53        
Settlement of contingent consideration (in shares)     440,000          
Settlement of contingent consideration 960     960        
Stock-based compensation expense and other 52,573     52,573        
Foreign currency translation adjustment (1,599)           (1,599)  
Net loss $ (302,891)       (302,891)      
Ending balance (in shares) at Sep. 30, 2023 1,972,725,000   1,972,725,000          
Ending balance at Sep. 30, 2023 $ 1,252,683   $ 198 $ 6,334,218 $ (5,078,834)   $ (2,899)  
[1] As adjusted to reflect the impact of the adoption of ASC 842 as of January 1, 2022. See Note 1 for a summary of the adjustments.
[2] As adjusted to reflect the impact of the adoption of Accounting Standards Codification Topic 842, Leases (“ASC 842”) as of January 1, 2022. See Note 1 for a summary of the adjustments.
[3] As adjusted to reflect the impact of the adoption of ASC 842 as of January 1, 2022. See Note 1 for a summary of the adjustments.
[4] As adjusted to reflect the impact of the adoption of ASC 842 as of January 1, 2022. See Note 1 for a summary of the adjustments.